摘要:
Nitrogen-containing tetracyclic compounds represented by general formula (I) or pharmaceutically acceptable salts thereof, wherein Y1-Y2-Y3 represents N-C=N or C=C-NR3 (wherein R3 represents hydrogen, C¿1-5? alkyl or nitrogen-containing C2-10 alkyl); Y?4¿ represents S, SO, SO¿2?, CH2 or NR?4¿ (wherein R4 represents C¿1-5? alkanoyl or C1-5 alkyl); R?1 and R2¿ are the same or different and each represents hydrogen, C¿1-10? alkyl, C3-15 alkoxyalkyl or C3-15 alkylaminoalkyl, or R?1 and R2¿ form together with the adjacent nitrogen atom cyclic amino; X?1 and X2¿ are the same or different and each represents hydrogen, C¿1-5? alkyl, C1-5 alkoxy or halogeno; and n is 0, 1 or 2.
摘要:
Heteroaromatic derivatives represented by general formula (I) or pharmacologically acceptable salts thereof, wherein Z represents a group represented by general formula (II), (III), (IV) or (V) (wherein Ar1 represents phenyl optionally substituted by a halogen or C¿1-5? alkyl; R?2¿ represents a C¿1-5? alkyl; and Y represents hydrogen, mercapto, a C1-5 alkylthio, or amino optionally substituted by one or two C1-5 alkyls); Ar?2¿ represents phenyl optionally having one or two substituents selected among halogens, C¿1-5? alkyls, C1-5 alkoxys, hydroxy, and trifluoromethyl; B?1-B2¿ represents CH-CO or C=C(R1) (wherein R1 represents hydrogen or a C¿1-5? alkyl); and n is an integer of 1 to 4. The compounds are dopamine D4 receptor antagonists having a psychotropic action without causing extrapyramidal disorders.
摘要:
1,2-Dihydro-2-oxoquinoline derivatives represented by general formula (I) or pharmacologically acceptable salts thereof, wherein Ar represents pyridyl or group represented by general formula (II) (wherein X?3 and X4¿ are the same or different and each represents hydrogen, halogeno, C¿1-5? alkyl, C1-5 alkoxy, hydroxy, or trifluoromethyl); Y represents nitrogen, CH, or C(OH); R?1 and R2¿ are the same or different and each represents hydrogen, C¿1-10? alkyl, C3-15 alkoxyalkyl, or C3-15 alkylaminoalkyl or R?1 and R2¿ form a cycloamino group together with the adjacent nitrogen atom; X?1 and X2¿ are the same or different and each represents hydrogen, C¿1-5? alkyl, C1-5 alkoxy, or halogeno or X?1 and X2¿ together represent alkylenedioxy; and n is an integer of 1 to 3.
摘要:
2-Carbonylthiazole derivatives represented by general formula (I) or pharmaceutically acceptable salts thereof (wherein Ar?1 and Ar2¿ represent each phenyl optionally having one or two substituents selected from among halogeno, C¿1-5? alkyl, trifluoromethyl, C1-5 alkoxy and hydroxy or thienyl; R?1¿ represents C¿1-5? alkoxy, hydroxy or amino represented by the formula N(R?3)R4¿ (wherein R?3 and R4¿ represent each hydrogen or C¿1-5? alkyl, or R?3 and R4¿ together with the nitrogen atom to which they are bonded may form pyrrolidino, piperidino, morphorino or piperazino optionally having one to four substituents selected from among C¿1-5? alkyl, C1-5 alkoxy and hydroxy); Y?1-Y2¿ represents CH-CO or C=C(R2) (wherein R2 represents hydrogen or C¿1-5? alkyl); and n is an integer of 1 to 4); drugs comprising the derivatives represented by the above general formula (I) or pharmaceutically acceptable salts thereof; and dopamine D4 receptor antagonists containing as the active ingredient the same. These drugs are useful as preventives and remedies for various diseases in which dopamine D4 receptors participate, for example, schizophrenia, cerebrovascular disorders and problematic behaviors accompanying senile dementia without showing any extrapyramidal disorders as the side effect.
摘要:
Thiazole derivatives represented by general formula (I) or pharmaceutically acceptable salts thereof, wherein Ar1 represents optionally substituted phenyl or thienyl; Y?1 and Y2¿ are different from each other and each represents nitrogen or sulfur; R1 represents hydrogen, C¿1-5? alkyl, phenyl or amino which may be mono- or di-substituted by C1-5 alkyl; and R?2¿ represents an optionally substituted nitrogen-containing heterocycle. The compounds are a dopamine D¿4? receptor antagonist which has an antipsychotic effect without causing any extrapyramidal disorder.
摘要翻译:由通式(I)表示的噻唑衍生物或其药学上可接受的盐,其中Ar1表示任选取代的苯基或噻吩基; Y 1和Y 2'彼此不同且各自代表氮或硫; R1代表氢,C 1-5 - 烷基,苯基或可被C 1-5烷基单取代或二取代的氨基; R 2'代表任意取代的含氮杂环。 这些化合物是一种多巴胺D4- 受体拮抗剂具有抗精神病作用而不引起任何锥体束外疾病。
摘要:
2-Amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives represented by the following general formula (I), pharmaceutically acceptable salts thereof or hydrates of the same. These compounds are useful as drugs, in particular, group 2 matabotropic glutamate receptor agonists having therapeutic and preventive effects on, for example, psychiatric diseases such as schizophrenia, anxiety and diseases associating the same, depression and bipolar disorder and neurological diseases such as drug addiction, cognition disorder, Alzheimer's disease, Huntington's chorea, Parkinson's disease, movement disorder associating muscular rigidity, cerebral ischemia, cerebral insufficiency, spinal disorder and head disorder.
摘要:
Carbamoyl tetrahydropyridine derivatives represented by general formula (1) and being efficacious against CRF-related diseases; medicinally acceptable salts of the same; and intermediates for the preparation thereof, wherein R?1 and R2¿ are each independently hydrogen, C¿1?-C5 alkyl, or the like; Y?1-Y2 is (R4)C=C(R5), (R6¿)C=N, N=N, (R7)N-CO, or N=C(R?8); X1, X2 and X3¿ are each independently hydrogen, halogeno, or the like; R?3, R4, R5 and R6¿ are each independently hydrogen or alkyl; R7 is hydrogen, C¿1?-C5 alkyl, or the like; and R?8¿ is hydrogen or carbamoyl.
摘要:
A cyclic amine compound represented by the following formula (1). It has potent adhesion inhibitory activity against an α2C receptor and is useful for the prevention or treatment of disorders attributable to the α2C receptor, e.g., diseases such as depression and anxiety. (Formula 1) (In the formula, X represents O, S, SO, SO2, NR2, etc.; R1 represents hydrogen, cyano, etc.; Ar1 and Ar2 each represents aryl, heteroaryl, etc.; ring B represents a benzene ring, etc.; n is an integer of 1 to 10; and p and q each is 1 or 2.)
摘要:
A process for producing a 2-oxobicyclo[3.1.0]hex-3-ene-6-carboxylic acid derivative represented by the formula (I) (wherein R1 represents hydrogen, C¿1-6? alkyl, C3-6 cycloalkyl, C1-6 alkyl substituted by C3-6 cycloalkyl, C1-6 alkyl substituted by optionally substituted phenyl, C1-6 alkyl substituted by C1-6 alkoxy, C1-6 hydroxyalkyl, C1-6 alkyl substituted by C1-6 alkylthio, C1-6 mercaptoalkyl, or optionally substituted phenyl), characterized by reacting a 4-hydroxy-2-oxobicyclo[3.1.0]hexane-6-carboxylic acid derivative represented by the formula (II) (wherein R?1¿ is the same as defined above; and R2 represents hydrogen or a hydroxyl-protecting group) in the presence of an acid or base. Also provided is a process for producing a compound useful in the efficient synthesis of a 2-amino-3-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative.